This product is slightly soluble in water and acidic solutions, and practically insoluble in ethanol. It is unstable in aqueous alkaline solutions. Solutions should be freshly prepared, as the product is rapidly oxidized by air and may darken when exposed to air and light.
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Acerca de este artículo
Fórmula lineal:
(HO)2C6H3CH2CH(NH2)CO2H
Número CAS:
Peso molecular:
197.19
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
2215169
Saltar a
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleInChI
1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1
SMILES string
N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O
InChI key
WTDRDQBEARUVNC-LURJTMIESA-N
grade
pharmaceutical primary standard
API family
levodopa
manufacturer/tradename
USP
mp
276-278 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
Gene Information
human ... DRD3(1814)
¿Está buscando productos similares? Visita Guía de comparación de productos
1 of 4
Este artículo | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename EDQM | manufacturer/tradename BP | manufacturer/tradename - |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) pharmaceutical (small molecule) |
| format neat | format neat | format neat | format neat |
| API family levodopa | API family levodopa | API family levodopa | API family levodopa |
| mp 276-278 °C (lit.) | mp 276-278 °C (lit.) | mp 276-278 °C (lit.) | mp 276-278 °C (lit.) |
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Levodopa USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Carbidopa and Levodopa Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Carbidopa and Levodopa Extended-Release Tablets
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Comparable product
Referencia del producto
Descripción
Precios
Related product
Referencia del producto
Descripción
Precios
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Clase de almacenamiento
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Carbidopa and Levodopa Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 47(5) (2022)
Levodopa
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(1), 2604-2604 (2020)
Carbidopa and Levodopa Extended-Release Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(3), 753-753 (2018)
Carbidopa and Levodopa Orally Disintegrating Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(1), 759-759 (2022)
Lukas L Imbach et al.
Parkinsonism & related disorders, 20(11), 1283-1286 (2014-09-28)
Diagnosis and treatment of tremor are largely based on clinical assessment. Whereas in some patients tremor may respond to dopaminergic treatment, in general l-Dopa response to tremor varies considerably. The aim of this study was to predict l-Dopa response by
-
Hi, I hope this message finds you well. We would like to order the Levodopa (1361009 USP), could you please let me know how should we dissolve the reagent and how to store the solution? How long can we store the solution for cell culture use? Thank you!
1 respuesta-
¿Le ha resultado útil?
-
Filtros activos
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico